Review
Behçet’s syndrome and ocular involvement: changes over time
C. Posarelli1, M.N. Maglionico2, R. Talarico3, G. Covello4, M. Figus5
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Italy.
- Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Italy. michele.figus@unipi.it
CER13788
2020 Vol.38, N°5 ,Suppl.127
PI 0086, PF 0093
Review
Free to view
(click on article PDF icon to read the article)
PMID: 33253088 [PubMed]
Received: 07/07/2020
Accepted : 12/11/2020
In Press: 18/11/2020
Published: 10/12/2020
Abstract
Ocular involvement in Behçet’s syndrome still represents a challenge for both rheumatologists and ophthalmologists; over the past 20 years the availability of new diagnostic tools and the concomitant introduction of biologic drugs led to a significant improvement in the management of these patients. The lack of uniform definitions and the diversity of the outcome measures still represent an obstacle for the prompt and correct management of ocular manifestations. The aim of the present review is to summarise the current evidences related to correct diagnosis and proper management of patients with Behçet’s syndrome and ocular involvement.
